As a contract research organisation working to current regulatory standards, BioAnaLab is able to supply a range of services and especially enjoys bioanalytical challenges which others have found difficult. The bioanalytical service is applicable at any stage in drug development from the QC testing of the manufactured drug, through pre-clinical and clinical trials to post-market surveillance. For a small Biotech company which is focusing resources on drug development and proof-of-principle testing, BioAnaLab can provide expert support at an early stage by establishing robust and well-validated assays which will soon be critical on the regulatory path. For a larger company which might already have bioanalytical capabilities in house, BioAnaLab can bridge the resource gaps that occur when large scale clinical trials begin. Besides the core technologies of flow cytometry, ELISA and surface plasmon resonance, BioAnaLab welcomes other bioanalytical problems - contact us for more details.